tiprankstipranks
Sirona Biochem’s Breakthrough in Anti-Aging Skincare
Company Announcements

Sirona Biochem’s Breakthrough in Anti-Aging Skincare

Sirona Biochem (TSE:SBM) has released an update.

Don't Miss Our Christmas Offers:

Sirona Biochem’s GlycoProteMim has been recognized in Stonegate Healthcare’s report as a notable innovation in the $12.5 billion anti-aging skincare market. The ingredient stands out for its dual action on surface-level appearance and cellular mechanisms, offering a potentially safer and non-invasive alternative to traditional treatments like Botox and dermal fillers. Sirona Biochem is poised to launch GlycoProteMim through Sirona Laboratories in Europe and North America in early 2025.

For further insights into TSE:SBM stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskSirona Biochem Unveils Promising Anti-Aging Compound
TipRanks Canadian Auto-Generated NewsdeskSirona Biochem’s 2025 Market Debut with Anti-Aging Serum
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App